Sujatha Kannan MD
@SujathaKannanMD
Professor @HopkinsACCM @HopkinsMedicine, #PedsICU Neurocritical care. Research- nanotherapies, neuroinflammation, neurodevelopmental disorders. Inventor/Biotech
20-08-2020 11:46:55
37 Tweets
309 Followers
114 Following
An experimental treatment called OP-101 reduced the risk of death and need for a ventilator in a study of 24 severely ill adults hospitalized with COVID-19, say Johns Hopkins scientists. hopkinsmedicine.org/news/newsroom/… via Hopkins Med News